Mayo Clinic Proceedings: Innovations, Quality & Outcomes (Dec 2018)

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient

  • Jesus Vera-Aguilera, MD,
  • Narjust Duma, MD,
  • Kelly Gast, MD,
  • Hassan Alkhateeb, MD,
  • Aaron Tande, MD,
  • Nelson Leung, MD,
  • William J. Hogan, MB ChB,
  • Saad J. Kenderian, MB ChB

Journal volume & issue
Vol. 2, no. 4
pp. 387 – 391

Abstract

Read online

We report the development of a Shiga toxin–producing Escherichia coli O157 gastrointestinal infection associated with hemolytic uremic syndrome in an allogenic stem cell transplant recipient with a history of gastrointestinal graft-vs-host disease receiving long-term immunosuppression.